ACKO acquires digital health platform, Parentlane to strengthen its content and healthcare delivery capabilities

ACKO has acquired Parentlane, a leading digital health platform in the maternity & child health space. The technology platform empowers young millennial parents with proactive healthcare solutions from preconception to the most critical early childhood development phase. The platform, combined with ACKO's core insurance offering, will deliver personalised content and services to enable better healthcare choices, informed decisions, and improved outcomes. For young millennial parents, who comprise most of ACKO's customer segment, maternal care is the first in-depth hospitalisation or healthcare experience. With this acquisition, ACKO improves its ability to not only provide continuum care for maternal care but also aims to develop specialised care programmes for many other conditions. Varun Dua, founder, ACKO, said, "We are constantly working towards strengthening the customer value proposition, and the Parentlane acquisition is a step in that direction. As both ACKO and Parentlane seek to address the problems in healthcare, there is total alignment in our respective philosophies. Parentlane has built a successful engagement-led technology platform for maternal health, which we believe will play a significant role in helping us provide comprehensive healthcare service to our customers and expand beyond the core insurance offerings by partnering with the healthcare ecosystem." Vijay Anand, co-founder and CEO, Parentlane, will join the Acko leadership team and spearhead strategic initiatives for the company. "Parentlane currently serves over 2 million users yearly on the platform with personalized content and delivers healthcare services by partnering with many leading hospitals across the country. In addition, the company has built a rich repository of 10,000+ content pieces in multiple formats, which the platform leverages to personalise information based on customer lifecycle stages and various health conditions," said Anand.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!